ChiCTR2500105706 版本V1.0 版本创建时间2025/07/09 10:57:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500105706 

最近更新日期:

Date of Last Refreshed on:

2025-07-09 10:57:47 

注册时间:

Date of Registration:

2025-07-09 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

上海临床队列—脊髓损伤(储备)

Public title:

Shanghai Clinical Cohort - Spinal Cord Injury (Reserve)

注册题目简写:

English Acronym:

研究课题的正式科学名称:

上海临床队列—脊髓损伤(储备)

Scientific title:

Shanghai Clinical Cohort - Spinal Cord Injury (Reserve)

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈吉保 

研究负责人:

靳令经 

Applicant:

Chen Jibao 

Study leader:

Jin Lingjing 

申请注册联系人电话:

Applicant telephone:

+86 21 3773 0011

研究负责人电话:

Study leader's
telephone:

+86 21 3773 0011

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lanbao_08@163.com

研究负责人电子邮件:

Study leader's E-mail:

lingjingjin@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市松江区光星路2209号

研究负责人通讯地址:

上海市松江区光星路2209号

Applicant address:

No. 2209, Guangxing Road, Songjiang District, Shanghai

Study leader's address:

No. 2209, Guangxing Road, Songjiang District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

201619

研究负责人邮政编码:

Study leader's postcode:

201619

申请人所在单位:

上海市养志康复医院(上海市阳光康复中心 )

Applicant's institution:

Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)

研究负责人所在单位:

上海市养志康复医院(上海市阳光康复中心 )

Affiliation of the Leader:

Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

养志伦审字(2025) 041号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市养志康复医院(上海市阳光康复中心)医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)

伦理委员会批准日期:

Date of approved by ethic committee:

2025-06-25 00:00:00

伦理委员会联系人:

翟华

Contact Name of the ethic committee:

Zhai Hua

伦理委员会联系地址:

上海市松江区光星路2209号

Contact Address of the ethic committee:

No. 2209, Guangxing Road, Songjiang District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 3773 0011

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市养志康复医院(上海市阳光康复中心)

Primary sponsor:

Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)

研究实施负责(组长)单位地址:

上海市松江区光星路2209号

Primary sponsor's address:

No. 2209, Guangxing Road, Songjiang District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市养志康复医院(上海市阳光康复中心)

具体地址:

上海市松江区光星路2209号

Institution
hospital:

Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)

Address:

No. 2209, Guangxing Road, Songjiang District, Shanghai

经费或物资来源:

上海市财政专项资金

Source(s) of funding:

Special funds of the Shanghai Municipal Finance

研究疾病:

脊髓损伤  

Target disease:

Spinal cord injury

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

建立一个临床队列对于脊髓损伤的研究和临床应用具有重要意义,通过标准化的数据收集、临床试验的经验总结以及再生医学的进步,为药械研发的创新策源和临床试验的加速提质提供重要基础性支撑,未来的治疗和康复方案将更加精准和有效。  

Objectives of Study:

The summary of experimental experience and the progress of regenerative medicine provide important fundamental support for the innovative origin of drug and medical device research and development and the acceleration and quality improvement of clinical trials. Future treatment and rehabilitation plans will be more precise and effective.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄>=18岁; 2.符合脊髓损伤诊断标准且经脊柱CT或MRI检查诊断明确; 3.本人或家属愿意签署知情同意书

Inclusion criteria

1. Age>=18 years; 2. Meet the diagnostic criteria for spinal cord injury and be diagnosed by spine CT or MRI examination; 3. The person or family member is willing to sign the informed consent form

排除标准:

1.严重认知功能障碍或精神疾病患者,不能配合评估及训练者; 2.有严重疾病,预期无法完成6个月随访患者

Exclusion criteria:

1. Patients with severe cognitive impairment or mental illness who cannot cooperate with assessment and training; 2. Patients with severe illness who are expected to be unable to complete the 6-month follow-up

研究实施时间:

Study execute time:

From 2025-07-01 00:00:00 To 2025-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-07-10 00:00:00 To 2025-12-31 00:00:00

干预措施:

Interventions:

组别:

脊髓损伤观察组

样本量:

450

Group:

Spinal Cord Injury Observation Group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市同济医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Tongji Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

海军军医大学第二附属医院 

单位级别:

三甲 

Institution
hospital:

The Second Affiliated Hospital of Naval Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属华山医院 

单位级别:

三甲 

Institution
hospital:

Huashan Hospital Affiliated to Fudan University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第一人民医院 

单位级别:

三甲 

Institution
hospital:

Shanghai General Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属岳阳中西医结合医院 

单位级别:

三甲 

Institution
hospital:

ueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第六人民医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Sixth People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

脊髓MRI

指标类型:

主要指标

Outcome:

Spinal cord MRI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脊髓损伤神经学分类国际标准

指标类型:

主要指标

Outcome:

International Standard for Neurological Classification of Spinal Cord Injury

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

改良Ashworth痉挛量表评分

指标类型:

主要指标

Outcome:

Modified Ashworth Spasm Scale score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

痉挛频率量表评分

指标类型:

主要指标

Outcome:

Spasticity frequency scale score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Vas评分

指标类型:

主要指标

Outcome:

Visual Analogue Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

三级坐位平衡

指标类型:

主要指标

Outcome:

Third-level sitting balance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

三级立位平衡

指标类型:

主要指标

Outcome:

Three-level upright balance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脊髓损伤独立能力评估量表

指标类型:

主要指标

Outcome:

Spinal Cord Independence Measure, SCIM-III

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

改良Barthel指数

指标类型:

主要指标

Outcome:

Modified B

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

神经源性膀胱简易评估

指标类型:

主要指标

Outcome:

Simple assessment of neurogenic bladder

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

神经源性肠道简易评估

指标类型:

主要指标

Outcome:

Simple assessment of neurogenic

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心理与社会支持

指标类型:

主要指标

Outcome:

Psychological and social support

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

并发症评估

指标类型:

主要指标

Outcome:

Complication assessment

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据录入环节采用双重核查机制,由经过认证的数据录入员完成电子数据采集系统(EDC)的录入工作,确保数据质量。研究表单设计及数据管理方面,项目组开发了系列定制化的病例报告表(CRF),涵盖所有核心研究变量,并建立完善的数据字典和变量编码规则。同时配备专业的数据管理团队,负责数据的清洗、质控和归档工作。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data entry process adopts a dual verification mechanism. Certified data entry officers complete the data entry work in the Electronic Data Capture (EDC) to ensure data quality. In terms of research form design and data management, the project team developed a series of customized case report forms (CRFS), covering all core research variables, and established a complete data dictionary and variable coding rules. At the same time, a professional data management team is equipped to be responsible for data cleaning, quality control and archiving.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-07-09 10:57:47